Skanska to build for pharmaceutical company in New Jersey for USD 60.5 M, about SEK 410 M

Skanska has been chosen as construction manager for expansion of a pharmaceutical facility in New Jersey. The contract amount totals USD 60.5 M, or approximately SEK 410 M, which will be included in order bookings for the fourth quarter. The customer is one of Skanska’s repeat customers within the pharmaceutical industry.